Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of the Triglyceride Glucose Index As a Measure of Insulin Resistance With Mortality and Cardiovascular Disease in Populations From Five Continents (Pure Study): A Prospective Cohort Study Publisher



Lopezjaramillo P1 ; Gomezarbelaez D1 ; Martinezbello D1 ; Abat MEM2 ; Alhabib KF3 ; Avezum A4 ; Barbarash O5 ; Chifamba J6 ; Diaz ML7 ; Gulec S8 ; Ismail N9 ; Iqbal R10 ; Kelishadi R11 ; Khatib R12, 13 Show All Authors
Authors
  1. Lopezjaramillo P1
  2. Gomezarbelaez D1
  3. Martinezbello D1
  4. Abat MEM2
  5. Alhabib KF3
  6. Avezum A4
  7. Barbarash O5
  8. Chifamba J6
  9. Diaz ML7
  10. Gulec S8
  11. Ismail N9
  12. Iqbal R10
  13. Kelishadi R11
  14. Khatib R12, 13
  15. Lanas F14
  16. Levitt NS15
  17. Li Y16
  18. Mohan V17
  19. Mony PK18
  20. Poirier P19
  21. Rosengren A20
  22. Soman B21
  23. Wang C16
  24. Wang Y16
  25. Yeates K22
  26. Yusuf R23
  27. Yusufali A24
  28. Zatonska K25
  29. Rangarajan S26
  30. Yusuf S26
Show Affiliations
Authors Affiliations
  1. 1. Masira Research Institute, Universidad de Santander, Bucaramanga, Colombia
  2. 2. Division of Adult Medicine, Department of Medicine, Philippine General Hospital, Manila, Philippines
  3. 3. Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia
  4. 4. International Research Center, Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil
  5. 5. Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation
  6. 6. Physiology Unit, Department of Biomedical Sciences, University of Zimbabwe, Harare, Zimbabwe
  7. 7. Estudios Clinicos Latinoamerica and Instituto Cardiovascular de Rosario, Rosario, Argentina
  8. 8. Cardiology Department, Ankara University School of Medicine, Ankara, Turkey
  9. 9. Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  10. 10. Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan
  11. 11. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  12. 12. Advocate Aurora Research Institute, Advocate Aurora Health, Downers Grove, IL, United States
  13. 13. Institute of Community and Public Health, Birzeit University, Birzeit, Palestine
  14. 14. Universidad de La Frontera, Temuco, Chile
  15. 15. Chronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa
  16. 16. Medical Research & Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
  17. 17. Madras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India
  18. 18. Division of Epidemiology & Population Health, St John's Medical College & Research Institute, Bangalore, India
  19. 19. Faculte de Pharmacie, Universite Laval, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec City, QC, Canada
  20. 20. Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
  21. 21. Health Action by People, Medical College, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala, India
  22. 22. Department of Medicine, Queen's University, Kingston, ON, Canada
  23. 23. Independent University, Dhaka, Bangladesh
  24. 24. Tamani Foundation, Matemwe, Zanzibar, Tanzania
  25. 25. Department of Population Health, Wroclaw Medical University, Wroclaw, Poland
  26. 26. Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada

Source: The Lancet Healthy Longevity Published:2023


Abstract

Background: The triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulin resistance, an important pathway in the development of type 2 diabetes and cardiovascular diseases. However, the association of the TyG index with cardiovascular diseases and mortality has mainly been investigated in Asia, with few data available from other regions of the world. We assessed the association of insulin resistance (as determined by the TyG index) with mortality and cardiovascular diseases in individuals from five continents at different levels of economic development, living in urban or rural areas. We also examined whether the associations differed according to the country's economical development. Methods: We used the TyG index as a surrogate measure for insulin resistance. Fasting triglycerides and fasting plasma glucose were measured at the baseline visit in 141 243 individuals aged 35–70 years from 22 countries in the Prospective Urban Rural Epidemiology (PURE) study. The TyG index was calculated as Ln (fasting triglycerides [mg/dL] x fasting plasma glucose [mg/dL]/2). We calculated hazard ratios (HRs) using a multivariable Cox frailty model with random effects to test the associations between the TyG index and risk of cardiovascular diseases and mortality. The primary outcome of this analysis was the composite of mortality or major cardiovascular events (defined as death from cardiovascular causes, and non-fatal myocardial infarction, or stroke). Secondary outcomes were non-cardiovascular mortality, cardiovascular mortality, all myocardial infarctions, stroke, and incident diabetes. We also did subgroup analyses to examine the magnitude of associations between insulin resistance (ie, the TyG index) and outcome events according to the income level of the countries. Findings: During a median follow-up of 13·2 years (IQR 11·9–14·6), we recorded 6345 composite cardiovascular diseases events, 2030 cardiovascular deaths, 3038 cases of myocardial infarction, 3291 cases of stroke, and 5191 incident cases of type 2 diabetes. After adjusting for all other variables, the risk of developing cardiovascular diseases increased across tertiles of the baseline TyG index. Compared with the lowest tertile of the TyG index, the highest tertile (tertile 3) was associated with a greater incidence of the composite outcome (HR 1·21; 95% CI 1·13–1·30), myocardial infarction (1·24; 1·12–1·38), stroke (1·16; 1·05–1·28), and incident type 2 diabetes (1·99; 1·82–2·16). No significant association of the TyG index was seen with non-cardiovascular mortality. In low-income countries (LICs) and middle-income countries (MICs), the highest tertile of the TyG index was associated with increased hazards for the composite outcome (LICs: HR 1·31; 95% CI 1·12–1·54; MICs: 1·20; 1·11–1·31; pinteraction=0·01), cardiovascular mortality (LICs: 1·44; 1·15–1·80; pinteraction=0·01), myocardial infarction (LICs: 1·29; 1·06–1·56; MICs: 1·26; 1·10–1·45; pinteraction=0·08), stroke (LICs: 1·35; 1·02–1·78; MICs: 1·17; 1·05–1·30; pinteraction=0·19), and incident diabetes (LICs: 1·64; 1·38–1·94; MICs: 2·68; 2·40–2·99; pinteraction <0·0001). In contrast, in high-income countries, higher TyG index tertiles were only associated with an increased hazard of incident diabetes (2·95; 2·25–3·87; pinteraction <0·0001), but not of cardiovascular diseases or mortality. Interpretation: The TyG index is significantly associated with future cardiovascular mortality, myocardial infarction, stroke, and type 2 diabetes, suggesting that insulin resistance plays a promoting role in the pathogenesis of cardiovascular and metabolic diseases. Potentially, the association between the TyG index and the higher risk of cardiovascular diseases and type 2 diabetes in LICs and MICs might be explained by an increased vulnerability of these populations to the presence of insulin resistance. Funding: Full funding sources are listed at the end of the paper (see Acknowledgments). © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license
Other Related Docs
49. Association Between High Doses Consumption of Niacin and Type 2 Diabetes, Journal of Babol University of Medical Sciences (2012)